| 注册
首页|期刊导航|中国临床医学|雷替曲塞联合X线照射对人喉癌细胞Hep-2的协同作用

雷替曲塞联合X线照射对人喉癌细胞Hep-2的协同作用

王抒 李轩 乔田奎

中国临床医学2017,Vol.24Issue(6):879-883,5.
中国临床医学2017,Vol.24Issue(6):879-883,5.DOI:10.12025/j.issn.1008-6358.2017.20170522

雷替曲塞联合X线照射对人喉癌细胞Hep-2的协同作用

The synergistic effect of raltitrexed combined with X-ray radiation on human laryngeal cancer Hep-2 cells

王抒 1李轩 1乔田奎1

作者信息

  • 1. 复旦大学附属金山医院肿瘤科,上海201508
  • 折叠

摘要

Abstract

Objective:To investigate the synergistic effect of raltitrexed combined with radiotherapy on Hep-2 cells and its potential mechanism.Methods:CCK-8 assay was used to determine the cell viability after Hep-2 cells were treated with different concentrations of raltitrexed.Hep-2 cells were randomly divided into the control group,the raltitrexed group,the radiation group,and raltitrexed + radiation group.Cell survival curves were fitted with a single-hit multi-target model,cell viability and sensitization enhancement ratio(SNR) of the 4 groups were detected,and apoptosis and cycle changes of Hep-2 cells in 4 groups were detected by flow cytometry.Results:CCK-8 assay proved that raltitrexed could suppress cell viability in a dose-dependent manner.The single-hit multi-target model showed that the SER of mean death dose (D0) was 1.272.Furthermore,the apoptosis rate and the number of Hep-2 cells at G2/M phase were significantly increased in the group treated with the combination of raltitrexed and X-ray as compared to the group treated with X-ray alone (P<0.05).Conclusions:The inhibitory effect of raltitrexed combined with X-ray on human laryngeal cancer Hep-2 cells may be related to the induction of tumor cell apoptosis and the increase of G2/M phase arrest.

关键词

雷替曲塞/X线/Hep-2细胞/凋亡/细胞周期

Key words

raltitrexed/X-ray/Hep-2 cells/apoptosis/cell cycle

分类

医药卫生

引用本文复制引用

王抒,李轩,乔田奎..雷替曲塞联合X线照射对人喉癌细胞Hep-2的协同作用[J].中国临床医学,2017,24(6):879-883,5.

基金项目

上海市金山区卫生和计划生育委员会青年项目(JSKJ-KTQN-2014-01).Supported by the Jinshan District Health and Family Planning Commission Project in Shanghai (JSKJ-KTQN-2014-01). (JSKJ-KTQN-2014-01)

中国临床医学

OACSTPCD

1008-6358

访问量0
|
下载量0
段落导航相关论文